1021Guangdong Huayan Robotics Co., Ltd.

🇭🇰 Hong Kong Borsası
6.25
HKD
Analysis Scores
Lothien Robustness Score?
42/100
Moderate
Neden bu skor?
Damodaran ?
25/100
DCF hesaplanamadı (faaliyet kârı veya nakit akışı eksik)
Dalio Risk ?
85/100
Piotroski ?
4/9
Neutral
Graham ?
Negatif HBK
Company is loss-making (EPS = -0.0645 TL) — Graham formula requires positive earnings
Active Metric?
1/4
Confidence?
48%
Lothien Robustness Summary
29/100
Lothien Sağlamlık: Çok Zayıf (29/100)
Temel göstergelerin çoğu olumsuz. Lothien sağlamlık skoru düşük seviyede. | Kısa Vade: Olumsuz | Uzun Vade: Olumsuz | Pozitif: 3 | Negatif: 5 | Nötr: 0
Net Zarar
Son çeyrekte -HK$17M zarar açıklandı. Yatırımcı dikkatli olmalı.
Çeyreklik Kâr Düşüşü
Net kâr bir önceki çeyreğe göre %-499.6 geriledi (HK$4M → -HK$17M). Kısa vadede olumsuz sinyal.
Yıllık Kâr Geriledi
Geçen yılın aynı dönemine göre net kâr %-420.8 düştü. Uzun vadede endişe verici.
Net Nakit Pozisyonu
Şirketin nakdi borçlarından HK$68M fazla. Borç riski düşük.
Güçlü Likidite
Cari oran 3.55x — kısa vadeli borçları rahat karşılıyor.
FAVÖK Düşüşü
FAVÖK çeyreklik %-1596.7 düştü. Operasyonel performans zayıflıyor.
Negatif ROE
ROE: %-0.9. Şirket özsermayesini eritiyor.
Sonraki Çeyrek: Artış Beklentisi
Pusla tahminine göre bir sonraki çeyrekte kâr %+52.8 artabilir (-HK$17M → -HK$8M).

Data date 2026-10-22 Not investment advice; the figures are rule-based model output. How the scores are computed

Score record
Data date 2026-10-22
Update frequency Scheduled analysis run on business days at 19:30 Istanbul time; not every symbol is refreshed in every run

Method summaryThe Lothien Robustness Score (0-100) is a weighted combination of sub-scores computed by fixed rules from published financial statements and price data (Damodaran valuation, Dalio risk, Piotroski F-score, earnings quality, momentum and others). The rules are applied automatically to every covered stock, with weights that vary by sector.

AssumptionsCalculations rest on the company's latest published financial statements and on price data that may be delayed. Where four quarters have not been published, annual figures may be scaled from the available quarters. Model parameters such as the risk-free rate, the risk premium and long-term growth are fixed assumptions per exchange and contain no company-specific expectation.

Conflict of interestNo statement has been published on whether MIDAK, the operator of Lothien, or its team hold positions in these stocks. The figures are produced automatically by the same rules, without regard to any such position.

WarningThis information is not within the scope of investment advisory services and is not investment advice. The figures are the output of rule-based models and may not suit your financial situation or your risk and return preferences. Making an investment decision on the basis of this information alone may not lead to results that meet your expectations.

Model output; not investment advice; different models can disagree. Report an error

Risk Analysis (VaR) Çok Yüksek
139 days
Annual Volatility ?
%93.9
VaR 95% ?
%10.33
daily max loss
VaR 99% ?
%14.37
daily max loss
CVaR 95% ?
%10.85
expected loss (tail)
Max Drawdown ?
%74.4
24.04.2026 → 22.10.2026
Skewness ?
1.29
Parametrik%10.33
Historik%8.26
Cornish-Fisher%7.50
Return Distribution
Valuation
Potential?
+0.5%
ROIC ?
-3.6%
Debt Cycle?
Early Expansion
Balance Sheet Analysis? Q2026/6
Toplam borç: 17.1M HKD
Net nakit pozisyonunda: -1.2B HKD (borçsuz)
Borç/Özkaynak oranı düşük: 0.01x
Cari oran güçlü: 11.49x — yükümlülükler rahat karşılanıyor
Nakit ve benzerleri: 1.2B HKD
Ödenmiş sermaye: 557.1M HKD
Net işletme sermayesi pozitif: 2.2B HKD
Fiyat TRAMA-99 altında: %-32.2 — teknik trend olumsuz
Direnç seviyesi: TRAMA-99 = 9.21 HKD
Likit varlık ağırlığı yüksek: Dönen varlıklar toplam varlıkların %93'i
Fundamental & Technical Analysis
Profitability
Net Profit Margin %-13.5
Net profit margin %-13.5 — loss period. Compared to previous quarter -16.8 point decrease.
ROE - Return on Equity (TTM) %-2.0
ROE %-2.0 — negative return on equity.
EBITDA Margin %-16.2
EBITDA margin %-16.2 — operational loss.
Gross Profit Margin %37.7
Gross profit per revenue %37.7. Evaluate relative to sector.
Free Cash Flow Margin (TTM) %-7.3
TTM Free Cash Flow is %-7.3'i. Negative FCF — company consuming cash.
Valuation
P/B Ratio 1.48x Sector: 1.50x
PD/DD 1.48x — sector median (1.50x) below or near. Reasonable valuation.
Indebtedness
Current Ratio 11.49x
Current ratio 11.49x — current assets are 2x short-term liabilities. Very healthy liquidity.
Debt / Equity 0.01x
Low leverage — majority of assets financed by equity.
Interest Coverage -192.9x
Interest coverage -192.9x — critical level. Risk of difficulty in interest payments.
Growth
Revenue Growth (YoY) %+36.6
Revenue YoY %36.6 grew (2025/12) — strong growth. Sector expansion and/or market share increase.
Net Profit Growth (YoY) %-420.8
Net profit YoY %-420.8 declined (2025/12) — serious profit erosion.
Seasonality Analysis Q3 (Tem-Eyl)
Historically strongest quarter: Q3 (Jul-Sep) (avg. profit 4.7M). Weakest quarter: Q4 (Oct-Dec) (avg. profit -5.8M).
Score Explanations
Lothien Robustness
42/100
Moderate robustness (42/100). Valuation and risk criteria give mixed signals. Detailed review recommended.
Moderate
Potential
+0.5%
Plus %0.5 expected value (6.28) vs current price comparison. 1/4 valuation models could be calculated. Model confidence %48.
Components: P/B target: 6.31
Damodaran Valuation
25/100
Very Weak
Dalio Risk Analysis
85/100
Low debt risk (85/100). Interest coverage ratio -192.9x — weak, fragile.
Leverage: 100/100 | Debt Service: 100/100 | Quality: 27/100
ROIC - Return on Capital
%-3.6
ROIC (%-3.6) cost of capital (13.2%) below → destroying value.
WACC: %13.2
Debt Cycle Phase
Early Expansion
Debt decreasing, growth gaining momentum. Company in balance sheet cleanup phase.
Piotroski F-Score
4/9
Weak Piotroski (4/9). Many balance sheet quality criteria not met.
Neutral
Graham Intrinsic Value
—
Company is loss-making (EPS = -0.0645 TL) — Graham formula requires positive earnings
⚖️ Sector Comparison
P/B Ratio
1.48x vs 1.50x
Compared to sector %1 cheaper (by book value)
ROIC vs WACC
%-3.6 vs %13.2 WACC
ROIC 16.7 bps below cost of capital
Net Profit Margin (TTM)
%-7.7 vs %-9.3 EBITDA margin
TTM net profit margin %-7.7
TRAMA-99 Trend — Strong Downtrend
Price (6.25), TRAMA-99 line's %32.2 below. Significant downtrend. TRAMA line acts as strong technical resistance.
Price:: 6.25
TRAMA: 9.21
Difference: %-32.2
Charts
Indicators
BB deviation ?
RSI thresholds ?

Price Chart ?
RSI (14) ?
Bollinger Bands ?
MACD ?
Gold-Based Price + TRAMA (Stock / Gram Gold) ?
P/E Ratio ?
P/B Ratio ?
EBITDA ?
Net Working Capital ?
Current Ratio ?
1021 — Participation Finance Compliance
Loading…
The Lothien health scores and analyses on this page are for informational purposes only. They do not constitute investment advice. Please consult a licensed investment advisor before making investment decisions.